摘要
目的探讨经超声定位孕囊局部注射甲氨蝶呤（MTX）治疗子宫瘢痕妊娠（CSP）的临床疗效。方法选取2007年6月至2011年6月在我院接受治疗的剖宫产瘢痕部位妊娠患者58例，随机分为治疗组和对照组，两组分别接受孕囊局部注射和肌注甲氨蝶呤治疗。结果治疗组血β—HCG下降至正常的平均天数与附件包块完全吸收的平均天数低于对照组（P〈0．05），治疗组的治愈率（96．55％）高于对照组（58．62％），P〈0．05。结论经超声定位孕囊内注射MTX联合米非司酮口服治疗子宫瘢痕妊娠疗效好，并且无明显并发症，预后良好，适用于年轻、渴望生育的妇女。
Objective To investigate the effect of local injection of methotrexate （ MTX ） into the gestational sac under ultrasound localization in the treatment of Cesarean scar pregnancy （ CSP ）. Methods 58 women with CSP who had been hospitalized during the period of June 2007 to June 2011 were randomly divided into treatment and controlgroups, which were treated with MTX in the way of local injection of the gestational sac and intramuscular respectively. Results The treatment group cost less time to make β-HCG dropped to the normal and to absorb Accessory Kit completely than control group, （ P〈 0.05 ）. And the cure rate in treatment group was higher than that in control group, （ P 〈 0.05 ）.Conclusions The local injection of MTX with ultrasound localization in treatment to CSP has good effect, and no significant complications, which is good for young women who desire fertility.
出处
《国际医药卫生导报》
2012年第15期2210-2212,共3页
International Medicine and Health Guidance News
关键词
孕囊局部注射甲氨蝶呤
剖宫产瘢痕妊娠
Local injection of methotrexate into the gestational sac
Cesarean scar pregnancy
